• LLY-507: Advanced SMYD2 Inhibitor for Cancer and Fibrosis Re

  2026-06-15

  LLY-507 empowers researchers with selective SMYD2 inhibition, enabling precise interrogation of epigenetic regulation in cancer and kidney fibrosis models. Its robust selectivity and cell-active potency make it a cornerstone for apoptosis assays and cancer cell proliferation studies.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-15

  This study reveals significant sex-dependent differences in the development of angiotensin II-induced hypertension in conscious mice, highlighting the protective role of female sex hormones and the impact of autonomic ganglia signaling. The findings advance mechanistic understanding of blood pressure regulation and provide a foundation for future cardiovascular and autonomic nervous system research.

• MLKL Polymerization Drives Lysosomal Membrane Permeabilizati

  2026-06-14

  This study uncovers that MLKL polymerization at lysosomal membranes triggers permeabilization, releasing cathepsins and promoting necroptosis. The findings connect MLKL activity to lysosomal disruption, providing mechanistic insight into regulated cell death with implications for disease research.

• Trichostatin A (TSA): Protocols for Epigenetic and Cancer Re

  2026-06-13

  Trichostatin A (TSA) is a highly potent HDAC inhibitor used to modulate epigenetic marks and inhibit breast cancer cell proliferation in vitro and in vivo. It is best suited for applications investigating histone acetylation, cell cycle arrest, and differentiation, but requires precise handling due to solubility and stability limitations. TSA should not be used in workflows demanding long-term solution stability or water solubility.

• IEM 1460: Advanced Strategies for Selective AMPA Receptor In

  2026-06-12

  Explore the unique role of IEM 1460 as a selective AMPA receptor blocker in cutting-edge excitotoxicity and neuroprotection research. This article delivers a deeper analysis of translational assay design decisions, integrating new evidence and practical guidance for neuroscience workflows.

• CUDC-907: Protocol Guidance for Dual PI3K and HDAC Inhibitio

  2026-06-12

  CUDC-907 enables researchers to execute simultaneous inhibition of PI3K and HDAC pathways in controlled in vitro cancer models, especially where crosstalk between these signaling axes is relevant. It is not appropriate for diagnostic or clinical applications, and optimal outcomes require adherence to compound-specific handling and workflow parameters.

• PtrbZIP12 Phosphorylation Enhances Drought Tolerance in Popu

  2026-06-11

  This study uncovers how phosphorylation of the bZIP transcription factor PtrbZIP12 directly improves drought resistance in Populus trichocarpa by activating PtrDHN and PtrPOD genes. The findings highlight the mechanistic role of transcriptional and post-translational regulation in plant stress adaptation and offer a molecular framework for future research on protein phosphorylation in abiotic stress responses.

• OSMI-1 and the O-GlcNAc–HUWE1–TfR1 Axis: Translational Impac

  2026-06-11

  Explore how OSMI-1, a potent O-GlcNAc transferase inhibitor from APExBIO, is redefining the study of placental ferroptosis and protein O-GlcNAc modification. This thought-leadership article combines mechanistic insights, experimental best practices, and translational considerations, drawing from recent landmark studies and competitive intelligence to offer strategic guidance for researchers advancing preeclampsia and syncytialization research.

• CP-673451: Precision PDGFRα/β Inhibition for Translational O

  2026-06-10

  This article explores the mechanistic and translational landscape of CP-673451, a selective PDGFRα/β inhibitor, as a strategic tool in cancer research. It integrates mechanistic insight, emerging evidence on ATRX-deficient gliomas, competitive positioning, and actionable protocol guidance to empower translational researchers.

• Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Cell Dea

  2026-06-10

  The Annexin V-FITC/PI Apoptosis Assay Kit offers rapid, dual-parameter discrimination of apoptotic and necrotic cells, streamlining research workflows in apoptosis studies. Its robust one-step protocol and compatibility with advanced applications make it a trusted tool for both routine and high-impact translational research.

• GDH1 Protects Against Congenital Obstructive Nephropathy in

  2026-06-09

  This study uncovers a protective role for glutamate dehydrogenase 1 (GDH1) in congenital obstructive nephropathy (CON) using neonatal rodent models. By demonstrating that GDH1 overexpression mitigates renal fibrosis and apoptosis, the work points to GDH1 as a promising therapeutic target for veterinary medicine and highlights the value of precise apoptosis detection in mechanistic kidney research.

• Zosuquidar (LY335979): Transforming MDR Reversal in Cancer A

  2026-06-09

  Zosuquidar (LY335979) 3HCl empowers researchers to overcome multidrug resistance in cancer models by targeting P-glycoprotein efflux. This guide delivers evidence-based workflows, troubleshooting strategies, and recent breakthroughs—enabling robust, reproducible sensitization in challenging tumor systems.

• ATP Sensing and the NOX2/ROS Axis: Strategic Tools for Trans

  2026-06-08

  Explore how precise ATP measurement using the Luminescent ATP Detection Assay Kit advances mechanistic understanding and translational strategy in inflammatory bowel disease. This article integrates new insights on the NOX2/ROS/mitochondria/NLRP3 axis in ulcerative colitis, offers protocol guidance, and positions APExBIO's firefly luciferase ATP assay as a strategic asset for next-generation metabolic and redox research.

• Translating (R,S)-Anatabine Mechanisms into Alzheimer’s Stra

  2026-06-08

  (R,S)-Anatabine, a minor tobacco alkaloid, is emerging as a compelling tool in neurodegeneration research due to its dual inhibition of amyloidogenic and inflammatory pathways. This article provides translational researchers with a mechanistic deep dive, strategic workflow guidance, and a critical perspective on emerging evidence, including cross-domain insights from recent skin barrier studies. By synthesizing validated protocols and competitive considerations, it empowers research teams to drive (R,S)-Anatabine from bench to bedside with rigor and vision.

• Thrombin: Applied Protocols and Optimization in Coagulation

  2026-06-07

  Unlock reproducible and advanced coagulation assays with the ultra-pure Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] from APExBIO. This guide details experimental workflows, troubleshooting strategies, and real-world use cases that harness thrombin's precision as a trypsin-like serine protease.

14719 records 1/982 page Next 12345 下5页 Last page